CP
ABBV icon

Capital Planning’s AbbVie ABBV Stock Holding History

Capital Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Buy
19,416
+3,430
+21% +$738K 1.42% 23
2026
Q1 		$3.48M Hold
15,986
– – 1.13% 27
2025
Q4 		$3.67M Hold
15,986
– – 1.03% 28
2025
Q3 		$3.7M Buy
15,986
+14,831
+1,284% +$3.02M 1.08% 26
2025
Q2 		$214K Sell
1,155
-5,000
-81% -$929K 0.07% 79
2025
Q1 		$1.29M Sell
6,155
-84
-1% -$16.3K 0.36% 44
2024
Q4 		$1.11M Buy
6,239
+105
+2% +$19.3K 0.29% 44
2024
Q3 		$1.21M Buy
6,134
+50
+0.8% +$9.33K 0.34% 40
2024
Q2 		$1.04M Hold
6,084
– – 0.31% 41
2024
Q1 		$1.11M Buy
6,084
+934
+18% +$161K 0.36% 40
2023
Q4 		$798K Hold
5,150
– – 0.28% 46
2023
Q3 		$768K Hold
5,150
– – 0.3% 48
2023
Q2 		$694K Hold
5,150
– – 0.27% 46
2023
Q1 		$821K Hold
5,150
– – 0.34% 43
2022
Q4 		$832K Hold
5,150
– – 0.37% 48
2022
Q3 		$691K Sell
5,150
-2,854
-36% -$410K 0.39% 35
2022
Q2 		$1.23M Sell
8,004
-610
-7% -$93.2K 0.66% 30
2022
Q1 		$1.4M Hold
8,614
– – 0.54% 30
2021
Q4 		$1.17M Hold
8,614
– – 0.43% 38
2021
Q3 		$929K Sell
8,614
-42
-0.5% -$4.8K 0.38% 37
2021
Q2 		$975K Sell
8,656
-282
-3% -$31.8K 0.41% 38
2021
Q1 		$967K Sell
8,938
-428
-5% -$45.8K 0.43% 38
2020
Q4 		$1M Buy
+9,366
New +$900K 0.47% 38

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Capital Planning's ABBV Position: Q2 2026 in Review

Capital Planning increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $738K and bringing the position to 19,416 shares worth $4.89M. The position accounts for 1.42% of the portfolio, ranked #23.

Capital Planning first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Capital Planning held 19,416 shares of AbbVie worth $4.89M as of Q2 2026.
  • Capital Planning bought 3,430 AbbVie shares in Q2 2026, an estimated $738K.
  • AbbVie made up 1.42% of Capital Planning's portfolio in Q2 2026, its #23 holding.
  • Capital Planning first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Planning's 13F filing for Q2 2026, filed 22 Jul 2026.